Compass Pathways Plc (CMPS)
8.05
-0.21
(-2.54%)
USD |
NASDAQ |
Feb 20, 16:00
8.08
+0.03
(+0.37%)
After-Hours: 20:00
Compass Pathways EPS Diluted (Quarterly) : -1.436 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Silence Therapeutics Plc | -0.1479 |
| Adaptimmune Therapeutics Plc | -0.1163 |
| Biodexa Pharmaceuticals Plc | -- |
| Oxford Biomedica Plc | -- |
| NuCana Plc | -0.1348 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -136.86M |
| Total Expenses (Quarterly) | 136.86M |
| Enterprise Value | 621.80M |
| Earnings Yield | -33.29% |
| Normalized Earnings Yield | -25.77 |